Evidence map›Paper›PMID 27987272›Full record

ArticleMicrobiologyOpen2017

Agarolytic bacterium Persicobacter sp. CCB-QB2 exhibited a diauxic growth involving galactose utilization pathway.

Go Furusawa, Nyok-Sean Lau, Appalasamy Suganthi, Abdullah Al-Ashraf Amirul

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Go FurusawaCentre for Chemical Biology, Universiti Sains Malaysia, Bayan Lepas, Malaysia.
Nyok-Sean LauCentre for Chemical Biology, Universiti Sains Malaysia, Bayan Lepas, Malaysia.
Appalasamy SuganthiCentre for Chemical Biology, Universiti Sains Malaysia, Bayan Lepas, Malaysia.
Abdullah Al-Ashraf AmirulCentre for Chemical Biology, Universiti Sains Malaysia, Bayan Lepas, Malaysia.
Hospital Universiti Sains Malaysia · MYUniversiti Malaysia Kelantan · MYUniversiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The agarolytic bacterium Persicobacter sp. CCB-QB2 was isolated from seaweed (genus Ulva) collected from a coastal area of Malaysia. Here, we report a high-quality draft genome sequence for QB2. The Rapid Annotation using Subsystem Technology (RAST) annotation server identified four β-agarases (PdAgaA, PdAgaB, PdAgaC, and PdAgaD) as well as galK, galE, and phosphoglucomutase, which are related to the Leloir pathway. Interestingly, QB2 exhibited a diauxic growth in the presence of two kinds of nutrients, such as tryptone and agar. In cells grown with agar, the profiles of agarase activity and growth rate were very similar. galK, galE, and phosphoglucomutase genes were highly expressed in the second growth phase of diauxic growth, indicating that QB2 cells use galactose hydrolyzed from agar by its agarases and exhibit nutrient prioritization. This is the first report describing diauxic growth for agarolytic bacteria. QB2 is a potential novel model organism for studying diauxic growth in environmental bacteria.

Indexed as

AgarBacteroidetesBase SequenceDNA, BacterialEnergy MetabolismGalactoseGenome, BacterialGlycoside HydrolasesMalaysiaPhosphoglucomutaseSeaweedSequence Analysis, DNAAgaragaraseDNA, BacterialGalactoseGlycoside HydrolasesPhosphoglucomutaseagaraseagarolytic bacteriumdiauxic growthleloir pathwayPersicobacter

Identifiers

PMID27987272
PMCPMC5300873
OpenAlexW2562693275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.